275 related articles for article (PubMed ID: 25280865)
1. Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation.
Torres B; Guardo AC; Leal L; Leon A; Lucero C; Alvarez-Martinez MJ; Martinez MJ; Vila J; Martínez-Rebollar M; González-Cordón A; Gatell JM; Plana M; García F
J Int AIDS Soc; 2014; 17(1):19246. PubMed ID: 25280865
[TBL] [Abstract][Full Text] [Related]
2. CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression.
Fischer-Smith T; Tedaldi EM; Rappaport J
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):417-21. PubMed ID: 18373432
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of viremia and microbial translocation on immune activation in HIV-infected patients throughout ritonavir-boosted darunavir monotherapy.
BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutiérrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
Medicine (Baltimore); 2015 May; 94(17):e781. PubMed ID: 25929922
[TBL] [Abstract][Full Text] [Related]
4. Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women.
Martin GE; Gouillou M; Hearps AC; Angelovich TA; Cheng AC; Lynch F; Cheng WJ; Paukovics G; Palmer CS; Novak RM; Jaworowski A; Landay AL; Crowe SM
PLoS One; 2013; 8(1):e55279. PubMed ID: 23365694
[TBL] [Abstract][Full Text] [Related]
5. Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.
Younas M; Psomas C; Reynes C; Cezar R; Kundura L; Portales P; Merle C; Atoui N; Fernandez C; Le Moing V; Barbuat C; Moranne O; Sotto A; Sabatier R; Fabbro P; Vincent T; Dunyach-Remy C; Winter A; Reynes J; Lavigne JP; Corbeau P
Front Immunol; 2019; 10():2185. PubMed ID: 31572392
[TBL] [Abstract][Full Text] [Related]
6. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection.
Wilson EM; Singh A; Hullsiek KH; Gibson D; Henry WK; Lichtenstein K; Önen NF; Kojic E; Patel P; Brooks JT; Sereti I; Baker JV;
J Infect Dis; 2014 Nov; 210(9):1396-406. PubMed ID: 24813472
[TBL] [Abstract][Full Text] [Related]
7. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
Front Immunol; 2019; 10():2849. PubMed ID: 31867010
[No Abstract] [Full Text] [Related]
8. HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterations.
Teer E; Joseph DE; Driescher N; Nell TA; Dominick L; Midgley N; Deshpande G; Page MJ; Pretorius E; Woudberg NJ; Lecour S; Glashoff RH; Essop MF
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1146-H1157. PubMed ID: 30768357
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.
Tippett E; Cheng WJ; Westhorpe C; Cameron PU; Brew BJ; Lewin SR; Jaworowski A; Crowe SM
PLoS One; 2011; 6(5):e19968. PubMed ID: 21625498
[TBL] [Abstract][Full Text] [Related]
10. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
11. Viremic and Virologically Suppressed HIV Infection Increases Age-Related Changes to Monocyte Activation Equivalent to 12 and 4 Years of Aging, Respectively.
Angelovich TA; Hearps AC; Maisa A; Martin GE; Lichtfuss GF; Cheng WJ; Palmer CS; Landay AL; Crowe SM; Jaworowski A
J Acquir Immune Defic Syndr; 2015 May; 69(1):11-7. PubMed ID: 25647525
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses.
Liu Q; Ou Q; Chen H; Gao Y; Liu Y; Xu Y; Ruan Q; Zhang W; Shao L
BMC Infect Dis; 2019 Nov; 19(1):1006. PubMed ID: 31779590
[TBL] [Abstract][Full Text] [Related]
13. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.
Mavigner M; Delobel P; Cazabat M; Dubois M; L'faqihi-Olive FE; Raymond S; Pasquier C; Marchou B; Massip P; Izopet J
PLoS One; 2009 Oct; 4(10):e7658. PubMed ID: 19876401
[TBL] [Abstract][Full Text] [Related]
15. CD16-expressing monocytes correlate with arterial stiffness in HIV-infected ART-naïve men.
Luo L; Han Y; Song X; Zhu T; Zeng Y; Li T
HIV Clin Trials; 2018 Apr; 19(2):39-45. PubMed ID: 29770747
[TBL] [Abstract][Full Text] [Related]
16. Markers of T Cell Exhaustion and Senescence and Their Relationship to Plasma TGF-β Levels in Treated HIV+ Immune Non-responders.
Shive CL; Freeman ML; Younes SA; Kowal CM; Canaday DH; Rodriguez B; Lederman MM; Anthony DD
Front Immunol; 2021; 12():638010. PubMed ID: 33868264
[No Abstract] [Full Text] [Related]
17. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
Castley A; Berry C; French M; Fernandez S; Krueger R; Nolan D
PLoS One; 2014; 9(12):e115226. PubMed ID: 25544986
[TBL] [Abstract][Full Text] [Related]
18. Monocyte activation, HIV, and cognitive performance in East Africa.
Muñoz-Nevárez LA; Imp BM; Eller MA; Kiweewa F; Maswai J; Polyak C; Olwenyi OA; Allen IE; Rono E; Milanini B; Kibuuka H; Ake JA; Eller LA; Valcour VG
J Neurovirol; 2020 Feb; 26(1):52-59. PubMed ID: 31468471
[TBL] [Abstract][Full Text] [Related]
19. The independent effect of drug resistance on T cell activation in HIV infection.
Hunt PW; Deeks SG; Bangsberg DR; Moss A; Sinclair E; Liegler T; Bates M; Tsao G; Lampiris H; Hoh R; Martin JN
AIDS; 2006 Mar; 20(5):691-9. PubMed ID: 16514299
[TBL] [Abstract][Full Text] [Related]
20. Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels.
Barbosa RR; Silva SP; Silva SL; Tendeiro R; Melo AC; Pedro E; Barbosa MP; Santos MC; Victorino RM; Sousa AE
Clin Exp Immunol; 2012 Sep; 169(3):263-72. PubMed ID: 22861366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
